Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology.
Mavilio
Fulvio
F
Molecular Biology and Centre for Regenerative Medicine at University of Modena and Reggio Emilia, Modena, Italy. fulvio.mavilio@unimore.it
Ferrari
Giuliana
G
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D064987:Cell- and Tissue-Based Therapy / Q000639:trends*; D004268:DNA-Binding Proteins / Q000378:metabolism; D015316:Genetic Therapy / Q000009:adverse effects; D005822:Genetic Vectors; D006801:Humans; D060588:LIM Domain Proteins; D007938:Leukemia / Q000473:pathology; D008667:Metalloproteins / Q000378:metabolism; D011518:Proto-Oncogene Proteins; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D013234:Stem Cells / Q000166:cytology*; D013789:Thalassemia / Q000628:therapy
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins